Drug
Lad106
Lad106: highest development phase Phase 1, developed by Almirall. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Almirall
Trials
| Drug | Phase | Indication |
|---|---|---|
| LAD106 NCT07471932 | Phase 1 |
Latest
No recent events.
Follow Lad106 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.